Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 1;46(5):E349-E352.
doi: 10.1097/BRS.0000000000003805.

Factor XI Deficiency in a Patient with Cervical Spondylotic Myelopathy

Affiliations
Review

Factor XI Deficiency in a Patient with Cervical Spondylotic Myelopathy

Hisashi Serikyaku et al. Spine (Phila Pa 1976). .

Abstract

Study design: Case report.

Objective: To summarize the clinical manifestations and treatment of Factor XI deficiency in a patient with cervical spondylotic myelopathy.

Summary of background data: Factor XI deficiency is a rare genetic bleeding disorder caused by reduced levels and insufficient activity of a coagulation factor XI. It is claimed to be associated with prominent bleeding in case of trauma and surgery irrelevant to the FXI level. This is the first ever case of a patient with factor XI deficiency with cervical spondylotic myelopathy.

Methods: A case was investigated retrospectively and the relevant literature was reviewed.

Results: A 66-year-old man with a 2-months history of lack of finger dexterity and gait disturbance was referred to our department. He did not have a history of bleeding or coagulation disorder nor did his family. Magnetic resonance imaging (MRI) of the cervical spine revealed spinal canal stenosis at C3/4 to C5/6 and intramedullary hyperintensity at C3/4 on the :T2 weighted image (T2WI). Preoperative examination revealed no abnormal findings but a severe prolonged activated partial-thromboplastin time (APTT) of 139.8 seconds. Coagulation factor activity assay revealed severe deficiency of factor XI (<0.1%). In accordance with hematologist's recommendation, four units of fresh frozen plasma (FFP) were transfused on the day before surgery and APTT assayed early morning on the day of surgery was 70.5 seconds. An additional four units of FFP were transfused during the surgery and APTT was 60 seconds. The postoperative course was uneventful and the patient was discharged on the postoperative day 14.

Conclusion: Factor XI deficiency patients may develop excessive bleeding after trauma or surgery. Preoperative examination with prolonged APTT should be pursued until a diagnosis of is made. Under diagnosis of Factor XI deficiency, meticulous attentions are required for perioperative bleeding management including postoperative hematoma in spinal surgery.Level of Evidence: 5.

PubMed Disclaimer

References

    1. Bolton-Maggs PH. Factor XI deficiency and its management. Haemophilia 2000; 6:100–109.
    1. United Kingdom Haemophilia Centre Doctors Organization. Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. Haemophilia 2003; 9:1–23.
    1. Gomez K. Factor XI deficiency. Haemophilia 2008; 14:1183–1189.
    1. Bolton Maggs P. Factor XI deficiency - resolving the enigma? Haematol Edu Program 2009; 97–105.
    1. Mumford AD, Ackroyd S, Alikhan R, et al. Guidelines for the diagnosis and management of the rare coagulation disorders- a United Kingdom Haemophilia Centre Doctors’ Organization guideline on behalf of the British Committee for standards in Haematology. Br J Haematol 2014; 167:304–326.